Biotrin Opens R&D Facility to Develop MDx Technology | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Irish diagnostics shop Biotrin has officially opened its research and development facility in Dublin.

The facility was created as part of the company's project announced last year to develop its automated molecular diagnostics platform technology and assay reagents targeting DNA and RNA in infectious diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.